Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
3.090
+0.040 (1.31%)
Jul 23, 2025, 3:35 PM - Market open

Revelation Biosciences Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Revelation Biosciences.

Price Target: n/a
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for Revelation Biosciences.

Recommendation Trends

RatingDec '22Jan '23Feb '23
Strong Buy110
Buy000
Hold000
Sell000
Strong Sell000
Total110

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Roth MKM
Roth MKM
Strong Buy
Maintains
$7,200$21,600
Strong BuyMaintains$7,200$21,600+698,929.13%Feb 14, 2023
Roth Capital
Roth Capital
Strong Buy
Initiates
$604,800
Strong BuyInitiates$604,800+19,572,715.53%Feb 17, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 63.24M
Revenue Next Year
n/a
EPS This Year
-14.48
from -263.05
EPS Next Year
-5.94
from -14.48
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028FY 2029
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028Dec 31, 2029
Revenue
---33.64M63.24M
Revenue Growth
----88.01%---
EPS
-----263.05-14.48-5.94-5.66
EPS Growth
--------
Forward PE
--------
No. Analysts
-----433
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/an/a
Avgn/an/an/a
Lown/an/an/a

Revenue Growth

Revenue Growth20252026202720282029
High---
Avg---
Low---

EPS Forecast

EPS20252026202720282029
High-8.76-6.11-5.83
Avg-14.48-5.94-5.66
Low-19.65-5.70-5.44

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.